<div id="readability-page-1"><p>Bank of America Securities analyst Jason Zemansky reiterated a Buy rating on Werewolf Therapeutics today and set a price target of $7.00.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>According to TipRanks, Zemansky is a 5-star analyst with an average return of <span>21.3%</span> and a 60.64% success rate. Zemansky covers the Healthcare sector, focusing on stocks such as Cytokinetics, Kura Oncology, and Arcus Biosciences.</p> <p>Currently, the analyst consensus on Werewolf Therapeutics is a Strong Buy with an average price target of $7.50.</p></div>

HOWL

<p>Bank of America Securities analyst Jason Zemansky reiterated a Buy rating on Werewolf Therapeutics, setting a price target of $7.00. Zemansky, a 5-star analyst with a 21.3% average return, focuses on Healthcare stocks. The analyst consensus on Werewolf Therapeutics is a Strong Buy with an average price target of $7.50.</p>

Bank of America Securities Remains a Buy on Werewolf Therapeutics (HOWL)